| Bobbie Kolarik, | |
|
625 Walnut St, Mckeesport, PA 15132-2806 | |
| (412) 673-5005 | |
| Not Available |
| Full Name | Bobbie Kolarik |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 625 Walnut St, Mckeesport, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023677416 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT027725 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bobbie Kolarik, 625 Walnut St, Mckeesport, PA 15132-2806 Ph: () - | Bobbie Kolarik, 625 Walnut St, Mckeesport, PA 15132-2806 Ph: (412) 673-5005 |
News Archive
The Substance Abuse and Mental Health Services Administration (SAMHSA) is awarding over $19 million in Project LAUNCH (Linking Actions for Unmet Needs in Children's Health) grants to tribal and community-based programs over the next five years. Project LAUNCH promotes the wellness of children from birth to eight years of age by addressing the physical, emotional, social, cognitive and behavioral aspects of their development.
Véronique Bohbot, PhD., neuroscientist at the Douglas Mental Health University Institute and associate professor at McGill University, leads studies on navigational strategies. She presented her findings at the recent meeting of the Society for Neuroscience in San Diego, which could bring light into how we can make better use of our hippocampus in order to reduce the risk of dementia.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
Two separate studies in mice suggest that a class of interferons being evaluated in clinical trials as a therapy for COVID-19 may increase susceptibility to bacterial infections, depending on how long patients are exposed to it, and when they receive it.
Patients undergoing oncologic head and neck surgery do not benefit from thromboprophylaxis, report researchers.
› Verified 4 days ago
Joshua Streets, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 625 Walnut St, Mckeesport, PA 15132 Phone: 412-673-5005 | |
Caitlin Elizabeth Eiben, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1500 5th Ave, Mckeesport, PA 15132 Phone: 412-664-2485 | |
Jaimee Anderson, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 625 Walnut St, Mckeesport, PA 15132 Phone: 412-673-5005 | |
Dr. Meghan Kozusko Mays, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 625 Walnut St, Mckeesport, PA 15132 Phone: 412-673-5005 | |
Christina Walling, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 625 Walnut St, Mckeesport, PA 15132 Phone: 412-673-5005 | |
Rachel Klas, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 625 Walnut St, Mckeesport, PA 15132 Phone: 412-673-5005 |